| dc.contributor.author |
Ikonomopoulos, J |
en |
| dc.contributor.author |
Kokotas, S |
en |
| dc.contributor.author |
Gazouli, M |
en |
| dc.contributor.author |
Zavras, A |
en |
| dc.contributor.author |
Stoitsiou, M |
en |
| dc.contributor.author |
Gorgoulis, VG |
en |
| dc.date.accessioned |
2014-06-06T06:45:34Z |
|
| dc.date.available |
2014-06-06T06:45:34Z |
|
| dc.date.issued |
2003 |
en |
| dc.identifier.issn |
03044017 |
en |
| dc.identifier.uri |
http://dx.doi.org/10.1016/S0304-4017(03)00061-X |
en |
| dc.identifier.uri |
http://62.217.125.90/xmlui/handle/123456789/2510 |
|
| dc.subject |
Diagnosis |
en |
| dc.subject |
Leishmania spp. |
en |
| dc.subject |
PCR |
en |
| dc.subject |
Protozoa |
en |
| dc.subject.other |
animal experiment |
en |
| dc.subject.other |
animal tissue |
en |
| dc.subject.other |
antibody titer |
en |
| dc.subject.other |
article |
en |
| dc.subject.other |
aspiration |
en |
| dc.subject.other |
assay |
en |
| dc.subject.other |
blast cell |
en |
| dc.subject.other |
controlled study |
en |
| dc.subject.other |
diagnostic procedure |
en |
| dc.subject.other |
DNA determination |
en |
| dc.subject.other |
dog |
en |
| dc.subject.other |
evaluation |
en |
| dc.subject.other |
fluorescent antibody technique |
en |
| dc.subject.other |
intermethod comparison |
en |
| dc.subject.other |
kinetoplast |
en |
| dc.subject.other |
Leishmania |
en |
| dc.subject.other |
Leishmania chagasi |
en |
| dc.subject.other |
Leishmania donovani |
en |
| dc.subject.other |
leishmaniasis |
en |
| dc.subject.other |
lymph node |
en |
| dc.subject.other |
microscopy |
en |
| dc.subject.other |
nonhuman |
en |
| dc.subject.other |
parasitosis |
en |
| dc.subject.other |
polymerase chain reaction |
en |
| dc.subject.other |
sampling |
en |
| dc.subject.other |
veterinary medicine |
en |
| dc.subject.other |
Animals |
en |
| dc.subject.other |
DNA Primers |
en |
| dc.subject.other |
DNA, Kinetoplast |
en |
| dc.subject.other |
Dog Diseases |
en |
| dc.subject.other |
Dogs |
en |
| dc.subject.other |
Fluorescent Antibody Technique, Indirect |
en |
| dc.subject.other |
Greece |
en |
| dc.subject.other |
Leishmania |
en |
| dc.subject.other |
Leishmaniasis |
en |
| dc.subject.other |
Polymerase Chain Reaction |
en |
| dc.subject.other |
Reproducibility of Results |
en |
| dc.subject.other |
Canis familiaris |
en |
| dc.subject.other |
Leishmania donovani |
en |
| dc.subject.other |
Leishmania donovani chagasi |
en |
| dc.subject.other |
Leishmania infantum |
en |
| dc.subject.other |
Protozoa |
en |
| dc.title |
Molecular diagnosis of leishmaniosis in dogs: Comparative application of traditional diagnostic methods and the proposed assay on clinical samples |
en |
| heal.type |
journalArticle |
en |
| heal.identifier.primary |
10.1016/S0304-4017(03)00061-X |
en |
| heal.publicationDate |
2003 |
en |
| heal.abstract |
Leishmaniosis is a zoonotic, parasitic disease caused by members of the genus Leishmania. The disadvantages of the traditional methods have currently rendered the polymerase chain reaction (PCR), the most reliable alternative for the laboratory diagnosis of this disease. Several relevant protocols have been described in the past but their application is in most cases limited to research use. The latter combined with the diagnostic problems that can be caused by the genetic variability of the different Leishmania strains or the presence of PCR inhibitors, indicate that an alternative approach should be followed for the development of a standard diagnostic tool for leishmaniosis. In the present study, we have evaluated several PCR-based protocols, in order to identify a primer combination that would allow the reliable detection of Leishmania DNA from clinical material and the verification of its results, in a manner that could be applicable even for routine use. The evaluation consisted of a BLAST verification of the specificity of the previously described primers, PCR testing, and optimisation of the reaction conditions. Our assessment was completed with the comparative evaluation of the results produced by the proposed PCR assay, light microscopy, and indirect fluorescent antibody technique (IFAT), on clinical samples collected from dogs suspected of leishmaniosis. The proposed assay which consists of a combination of two pairs of primers, targeted to different areas of the kinetoplast DNA of Leishmania spp., specific for Leishmania infantum, Leishmania donovani and Leishmania chagasi, showed optimum performance on our test samples, and detected 41.9% Leishmania-positive dogs from our 160 clinical cases. From the same number of cases, 46.25% were positive by IFAT (titre ≥200), and 19% by microscopic examination of lymph node aspirates. © 2003 Elsevier Science B.V. All rights reserved. |
en |
| heal.journalName |
Veterinary Parasitology |
en |
| dc.identifier.issue |
2 |
en |
| dc.identifier.volume |
113 |
en |
| dc.identifier.doi |
10.1016/S0304-4017(03)00061-X |
en |
| dc.identifier.spage |
99 |
en |
| dc.identifier.epage |
113 |
en |